Fate Therapeutics, Inc. Common Stock (FATE)
x
x
x
FATE Analyst Research
FATE Analyst Ratings
| Symbol | Name | Rating |
|---|
Analyst Firms Making Recommendations
Analyst
$0.00
Based on analysts offering 12 month price targets for FATE in the last 3 months. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Sign in to your SmartPortfolio to see more analyst recommendations.
High $
Avg. $
Low $
Analyst price targets provided by TipRanks.